W.R. Berkley Corp’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

W.R. Berkley Corp’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-42,819	Closed	-$442K	–	230
2023 Q2	$442K	Buy	+42,819	New	+$439K	0.03%	204
2023 Q1	–	Sell	-130,972	Closed	-$1.32M	–	268
2022 Q4	$1.32M	Buy	130,972 +105,972	+424%	+$1.05M	0.07%	201
2022 Q3	$246K	Hold	25,000	–	–	0.01%	480
2022 Q2	$245K	Hold	25,000	–	–	0.01%	513
2022 Q1	$244K	Hold	25,000	–	–	0.01%	524
2021 Q4	$243K	Buy	+25,000	New	+$243K	0.01%	514

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

W.R. Berkley Corp's AONC Position: Q3 2023 in Review

W.R. Berkley Corp sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2023, closing a stake of 42,819 shares — an estimated $442K sold.

W.R. Berkley Corp first reported a position in AONC in Q4 2021 and held it in 6 quarters. The position peaked at $1.32M in Q4 2022. 3 funds tracked by Wall St. Rank hold AONC as of Q3 2023.

W.R. Berkley Corp reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
W.R. Berkley Corp sold 42,819 American Oncology Network, Inc. Class A Common Stock shares in Q3 2023, an estimated $442K.
W.R. Berkley Corp first reported a position in American Oncology Network, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
W.R. Berkley Corp's American Oncology Network, Inc. Class A Common Stock position peaked at $1.32M in Q4 2022.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2023.

Based on W.R. Berkley Corp's 13F filing for Q3 2023, filed 14 Nov 2023.